Gupta H, Joshi Y K, Tandon B N
Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi.
Liver. 1988 Apr;8(2):111-5. doi: 10.1111/j.1600-0676.1988.tb00977.x.
An enzyme-linked immunosorbent assay has been developed by using IgM antibodies from the acute stage as a source to capture the antigen in stools of patients with epidemic non-A, non-B (NANB) viral hepatitis. 29/69 (42.3%) of the patients and 3/9 (33.3%) contacts were positive for a suspected NANB viral antigen. However, only 1/27 (3.7%) of the negative controls drawn from amongst the patients with amoebiasis, giardiasis, hepatitis due to virus A and healthy individuals was positive for NANB antigen in the stool. The suspected NANB viral antigen was more frequently detected in stools collected between the 14th and 18th day of icteric hepatitis. The study suggests that IgM antibodies from patients with acute viral NANB hepatitis react with an antigen present in the stools of a high proportion of patients with epidemic NANB viral hepatitis. This serological test may be useful to establish the etiological diagnosis of non-A, non-B (fecal-oral) viral hepatitis. ELISA-positive stools contained 27 nm viral particles.
通过使用急性期的IgM抗体作为捕获抗原的来源,开发了一种酶联免疫吸附测定法,用于检测流行性非甲非乙型(NANB)病毒性肝炎患者粪便中的抗原。69例患者中有29例(42.3%)以及9名密切接触者中有3例(33.3%)的疑似NANB病毒抗原呈阳性。然而,从阿米巴病、贾第虫病、甲型病毒性肝炎患者及健康个体中抽取的阴性对照中,只有1/27(3.7%)的粪便NANB抗原呈阳性。在黄疸型肝炎第14天至18天收集的粪便中,更频繁地检测到疑似NANB病毒抗原。该研究表明,急性NANB病毒性肝炎患者的IgM抗体与流行性NANB病毒性肝炎患者粪便中存在的一种抗原发生反应。这种血清学检测可能有助于确立非甲非乙型(粪-口传播)病毒性肝炎的病因诊断。ELISA阳性的粪便中含有27纳米的病毒颗粒。